$1.29
0.77% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
US63008J1088
Symbol
NAOV

NanoVibronix, Inc. Stock price

$1.29
-4.81 78.85% 1M
-5.42 80.78% 6M
-5.20 80.12% YTD
-6.63 83.71% 1Y
-149.41 99.14% 3Y
-449.71 99.71% 5Y
-768.71 99.83% 10Y
Nasdaq, Closing price Tue, May 20 2025
-0.01 0.77%
ISIN
US63008J1088
Symbol
NAOV
Sector

Key metrics

Market capitalization $1.06m
Enterprise Value $430.00k
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.17
P/S ratio (TTM) P/S ratio 0.41
P/B ratio (TTM) P/B ratio 0.78
Revenue growth (TTM) Revenue growth 12.05%
Revenue (TTM) Revenue $2.56m
EBIT (operating result TTM) EBIT $-3.58m
Free Cash Flow (TTM) Free Cash Flow $-2.52m
Cash position $750.00k
EPS (TTM) EPS $-13.72
Short interest 14.42%
Show more

Is NanoVibronix, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

NanoVibronix, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast NanoVibronix, Inc.:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast NanoVibronix, Inc.:

Buy
100%

Financial data from NanoVibronix, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
2.56 2.56
12% 12%
100%
- Direct Costs 1.05 1.05
40% 40%
41%
1.51 1.51
2% 2%
59%
- Selling and Administrative Expenses 4.18 4.18
13% 13%
163%
- Research and Development Expense 0.91 0.91
379% 379%
36%
-3.58 -3.58
4% 4%
-140%
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -3.58 -3.58
4% 4%
-140%
Net Profit -3.71 -3.71
0% 0%
-145%

In millions USD.

Don't miss a Thing! We will send you all news about NanoVibronix, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

NanoVibronix, Inc. Stock News

Neutral
Business Wire
4 days ago
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in therapeutic devices, today announced the closing of its previously announced underwritten public offering of 400,000 shares of the Company's Series G Convertible Preferred Stock (“Preferred Stock”), with a par value $0.001 per share and a stated value ...
Neutral
Business Wire
6 days ago
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in therapeutic devices, today announced the pricing of an underwritten public offering of approximately 400,000 shares of the Company's Series G Convertible Preferred Stock (“Preferred Stock”), par value $0.001 per share and Warrants to purchase up to 4,9...
Neutral
Business Wire
9 days ago
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical technology company specializing in therapeutic devices, today announced findings from a recent retrospective case series evaluating the clinical impact and patient experience of the UroShield™ system. The case series, conducted between September 2023 and January 2025 by researchers at University Hospital...
More NanoVibronix, Inc. News

Company Profile

NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. It targets wound healing and pain therapy, and can be administered at home, without the assistance of medical professionals. Its products include WoundShield, PainShield, and UroShield. It operates through the following geographical segments: United States, Israel, United Kingdom, European Union, India, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Melville, NY.

Head office United States
CEO Brian Murphy
Employees 31
Founded 2003
Website www.nanovibronix.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today